The nation of Zimbabwe has turned down a major American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on confidential data.
This rejection came to light after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesman later clarified that the US was demanding access to genetic material for research and commercial gain but refused to share the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for continued dialogue to find a deal acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Implications
This development comes after a similar situation in neighbouring Kenya, where a court halted a similar deal with the US after legal challenges were filed about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to enhance openness and accountability.
As per statements, 16 African countries have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"In essence, our nation would provide the basic resources for medical research with no assurance that the resulting innovations would be available to our people if a new health crisis emerge."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks already established through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This system is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future collaboration might be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body expressed it acknowledged the official position, but recommended that negotiations should continue considering much of the country's Aids initiatives were funded by foreign aid.
"In cases where technical issues exist, such as those relating to information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it said.
The halted deal emphasises the ongoing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.